Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation — Wallis C. Y. Lau (2020) | RDL Network
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation
Article 2020 en
Authors
WL
Wallis C. Y. Lau
CC
Ching‐Lung Cheung
KM
Kenneth K. C. Man
Abstract
1 min read
The University of Hong Kong and University College London Strategic Partnership Fund.
Wallis C. Y. Lau, Esther W. Chan, Ching‐Lung Cheung, Chor‐Wing Sing, Kenneth K. C. Man, Professor Gregory Lip, Chung‐Wah Siu, Joanne K.Y. Lam, Alan C.H. Lee, Ian Chi Kei Wong
Wallis C. Y. Lau, Carmen Olga Torre, Kenneth K. C. Man, Henry Morgan Stewart, Sarah Seager, Mui Van Zandt, Christian Reich, Jing Li, Jack Brewster, Professor Gregory Lip, Aroon D. Hingorani, Li Wei, Ian Chi Kei Wong
Discussion(0)
No comments yet. Be the first to comment.